Erik Gatenholm

Erik Gatenholm is a Swedish-American entrepreneur and the co-founder and CEO of CELLINK, a leading bioconvergence company.13 Born in Sweden and raised in Blacksburg, Virginia, Gatenholm has made significant contributions to the field of 3D bioprinting.5

At the age of 28, Gatenholm co-founded CELLINK in 2016, creating the world's first universal bioprinting technology.1 The company designs state-of-the-art life science technologies used in over 2000 labs across more than 65 countries, including prestigious institutions like Harvard, MIT, Johnson & Johnson, Merck, and the FDA.1

Gatenholm's entrepreneurial journey began at 18 when he started his first biomedical device company, BC Genesis, in Virginia.2 He holds a degree in Business Management from Virginia Tech and an MBA from Gothenburg University.35

Under Gatenholm's leadership, CELLINK has achieved remarkable success:

1. Became the first bioink company in the world2
2. Listed on Nasdaq First North within ten months of founding5
3. Expanded to serve customers in about 50 countries3
4. Grew to employ approximately 700 engineers, scientists, and professionals1

Gatenholm has received numerous accolades for his work, including:

• Forbes 30 Under 30 (2018)14
• MIT Technology Review's 35 Under 351
• Young Entrepreneur of the Year1
• Innovator of the Year1
• Entrepreneur of the Year 20191
• Founder of the Year 20201

His vision for CELLINK is to change the future of medicine by providing technologies, products, and services to create, understand, and master cell and molecular biology.1 Gatenholm's passion for biotechnology, marketing, and facilitating change has driven CELLINK's growth and innovation in the field of 3D bioprinting.3